Important notice

Meds75+ – information regarding the use for persons aged 75+

Substances A-Z
  • Ra

  • Rabeprazolum natricum
    Class A
    Suitable for older persons. Over 8 weeks use only for high risk patients. In long term use, may reduce the absorption of calcium and vitamin B12.
  • Racecadotrilum
    Class B
    There is a lack of research evidence, clinical experience or efficacy among older persons. For short-term use only.
  • Ramiprilum
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose in even moderate renal insufficiency. Monitor renal function during the pharmacotherapy. Avoid concurrent use of anti-inflammatory analgesics.
  • Re

  • Repaglinidum
    Class D
    Avoid use in older persons. Risk of hypoglycaemia. Take several interactions into account.
  • Retinoli palmitas
  • Ri

  • Risperidonum
    Used as "PSYCHOLEPTICS"
    Class C
    Suitable for older persons, with specific cautions. Regularly assess the need for pharmacotherapy. Reduce the dose in even mild renal insufficiency. Significant adverse effects include cognitive disorder, confusion, extrapyramidal symptoms, orthostatic hypotension and risk of cardiovascular events. Increases risk for falls. Non-pharmacological treatments are the first line approach in the management of behavioral and psychological symptoms of dementia.
  • Rivaroxabanum
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose in even moderate renal insufficiency. A significant adverse effect is increased risk of bleeding. Take interactions into account. Andexanet alfa can be used as an antidote.
  • Rivastigminum
    Class C
    Suitable for older persons, with specific cautions. May exacerbate an existing COPD. Predisposes to cardiac conduction disorders, such as bradycardia. Note adverse effects affecting the gastrointestinal tract. Take interactions into account. Anticholinergic drugs weakens the efficacy of anti-Alzheimer´s drugs.

Icon explanation

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Mar 30, 2021.